Clinical trial
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
NCT00388635 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00388635 |
|---|---|
| Title | Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. |
| Official title | A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients. |
| Lead sponsor | PETHEMA Foundation, Other |
| Collaborators | Millennium Pharmaceuticals, Inc. Industry Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Velcade, Melphalan, Prednisone |
| Enrollment | 60 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Oct 17, 2006 |
| Last update posted | Jan 11, 2011 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: